These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20374036)

  • 1. Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells.
    Wang Y; Yang Z; Zhao X
    Toxicol Mech Methods; 2010 Jun; 20(5):234-41. PubMed ID: 20374036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Honokiol induces caspase-independent paraptosis via reactive oxygen species production that is accompanied by apoptosis in leukemia cells.
    Wang Y; Zhu X; Yang Z; Zhao X
    Biochem Biophys Res Commun; 2013 Jan; 430(3):876-82. PubMed ID: 23262230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
    Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER; Arlotti JA; Marynowski SW; Singh SV
    Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore.
    Li L; Han W; Gu Y; Qiu S; Lu Q; Jin J; Luo J; Hu X
    Cancer Res; 2007 May; 67(10):4894-903. PubMed ID: 17510419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells.
    Baran Y; Oztekin C; Bassoy EY
    Cancer Invest; 2010 Jul; 28(6):623-8. PubMed ID: 20307198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress.
    Chen YJ; Wu CL; Liu JF; Fong YC; Hsu SF; Li TM; Su YC; Liu SH; Tang CH
    Cancer Lett; 2010 May; 291(1):20-30. PubMed ID: 19880244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimetastatic activity of honokiol in osteosarcoma.
    Steinmann P; Walters DK; Arlt MJ; Banke IJ; Ziegler U; Langsam B; Arbiser J; Muff R; Born W; Fuchs B
    Cancer; 2012 Apr; 118(8):2117-27. PubMed ID: 21935912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of honokiol on proliferation and apoptosis of human cervical carcinoma cell line Hela in vitro].
    Yang GL; Hou WL; Fu AF; Zhong ZH; Yin XH; Chen LJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):558-62. PubMed ID: 18798493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytotoxic activities of Celecoxib on leukemic cells and the synergistic effects of Celecoxib with Imatinib thereupon].
    Li RJ; Gong FJ; Zhang GS
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(20):1417-20. PubMed ID: 16796927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib.
    La Rosée P; Jia T; Demehri S; Härtel N; de Vries P; Bonham L; Hollenback D; Singer JW; Melo JV; Druker BJ; Deininger MW
    Clin Cancer Res; 2006 Nov; 12(21):6540-6. PubMed ID: 17085669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
    Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
    Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells.
    Ou HC; Chou FP; Lin TM; Yang CH; Sheu WH
    Chem Biol Interact; 2006 May; 161(1):1-13. PubMed ID: 16580656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.
    Yu C; Rahmani M; Almenara J; Subler M; Krystal G; Conrad D; Varticovski L; Dent P; Grant S
    Cancer Res; 2003 May; 63(9):2118-26. PubMed ID: 12727828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro.
    Park EJ; Zhao YZ; Kim YH; Lee BH; Sohn DH
    Planta Med; 2005 Jan; 71(1):82-4. PubMed ID: 15678380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
    Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
    Li Z; Liu Y; Zhao X; Pan X; Yin R; Huang C; Chen L; Wei Y
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):95-102. PubMed ID: 18440692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.
    Gupta A; Le A; Belinka BA; Kachlany SC
    Leuk Res; 2011 Nov; 35(11):1498-505. PubMed ID: 21664691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.